NextGen AML stratification NGS Panel
NextGen AML stratification NGS Panel** Price
Brief Details
What Is the NextGen AML Stratification NGS Panel?
NextGen AML Stratification NGS Panel is an advanced genetic test that uses next-generation sequencing (NGS) technology to examine specific genes associated with acute myeloid leukaemia (AML). This test analyses DNA from your blood or bone marrow sample to identify genetic mutations in cancer cells.
The test helps doctors understand the unique genetic characteristics of your AML and determine the most appropriate treatment approach for your specific health condition.
What Does the NextGen AML Stratification NGS Panel Measure?
The NextGen AML Stratification NGS Panel provides detailed genetic information that helps personalise your cancer care:
- Genetic mutations: Identifies specific changes in genes that drive AML development
- Risk stratification: Classifies your AML into favourable, intermediate, or adverse risk categories
- Treatment targets: Finds genetic changes that can be treated with targeted therapies
- Disease prognosis: Helps predict how your cancer may respond to treatment
- Monitoring markers: Provides genetic markers to track treatment response and detect relapse
NextGen AML Stratification NGS Panel: Who Needs It and Why It's Done
What Symptoms May Call for the NextGen AML Stratification NGS Panel?
This test is ordered after an AML diagnosis, not based on initial symptoms. However, the symptoms that typically lead to AML diagnosis include:
- Persistent fever and frequent infections
- Extreme tiredness and weakness
- Shortness of breath during normal activities
- Pale skin and fatigue
- Easy bruising or unusual bleeding
- Tiny red spots on the skin (petechiae)
- Bone or joint pain
- Swollen lymph nodes
Who Should Get the NextGen AML Stratification NGS Panel?
The NextGen AML Stratification NGS Panel is specifically recommended for certain patient groups:
- Newly diagnosed AML patients: Standard part of initial diagnostic workup
- Adult patients with confirmed AML: Helps guide first-line treatment decisions
- Patients considering targeted therapy: Identifies suitable candidates for specific treatments
- Those requiring health risk assessment: Determines appropriate treatment intensity
Why Is the NextGen AML Stratification NGS Panel Done?
This test moves beyond standard treatment approaches by providing a detailed genetic blueprint of your specific cancer. It enables doctors to choose the most effective, personalised treatment strategy based on your cancer's unique genetic profile.
Importance of an AML Stratification NGS Panel
The NextGen AML Stratification NGS Panel revolutionises how doctors approach AML treatment by providing crucial genetic insights. This information helps determine whether you need standard chemotherapy, intensive treatment, or targeted therapies designed for your specific genetic mutations.
The test guides critical treatment decisions, including whether you might benefit from a bone marrow transplant early in your treatment journey. It also helps predict treatment response and provides markers to monitor your progress, making your cancer care more precise and effective.
NextGen AML Stratification NGS Panel Booking & Reports – Metropolis Healthcare India
How to Book the NextGen AML Stratification NGS Panel?
- Simple Online Booking
Booking can be done through the Metropolis Healthcare App or website. Select the 'NextGen AML Stratification NGS Panel', choose a convenient time slot, and provide your address for a blood test at home. You can also visit the nearest Metropolis Lab if you prefer to give the sample directly at the lab.
- Safe Home Sample Collection
Our trained phlebotomists ensure the timely collection of your sample while strictly following all safety and hygiene protocols.
- Sample Tracking Updates
Stay informed at every step. From collection to testing, you can track your sample directly through the Metropolis Healthcare website.
- Accurate Laboratory Testing
Your sample is processed at our NABL & CAP accredited laboratories, where expert technicians ensure accurate results.
- Quick & Easy Reports
Receive your test reports promptly via email, WhatsApp, or by downloading them directly from the Metropolis Healthcare website or app.
Is Home Sample Collection for the NextGen AML Stratification NGS Panel Available Near You?
Yes, home blood sample collection is available for the NextGen AML Stratification NGS Panel through Metropolis Healthcare. Our trained phlebotomists follow strict safety protocols while collecting your blood or bone marrow sample at home. With our extensive network of over 10,000 touchpoints across India, we're committed to making advanced cancer diagnostics accessible and convenient, offering tests for varied tumour markers.
How Long Does It Take to Get the NextGen AML Stratification NGS Panel Report?
Reports are usually available within 4 weeks once the sample reaches the pathology lab.
Note: Reporting time may vary depending on your location.
Where Can I See or Get NextGen AML Stratification NGS Panel Results?
Test results from Metropolis Healthcare can be accessed through multiple convenient channels. You can log in to the Metropolis website using your credentials or use the Metropolis Healthcare App to view and download your reports. Additionally, test reports are sent via email or WhatsApp, and you also have the option to collect a physical copy directly from the lab.
Interpreting NextGen AML Stratification NGS Panel Results
Your NextGen AML Stratification NGS Panel results provide detailed genetic information about your cancer. The report will indicate which genetic mutations were detected and their clinical significance for your treatment plan.
|
Component |
Finding |
Clinical Significance |
|
Gene Mutations |
Detected/Not Detected |
Guides targeted therapy selection and risk assessment |
|
Risk Stratification |
Favourable/Intermediate/Adverse |
Determines treatment intensity and prognosis |
|
Targetable Mutations |
Present/Absent |
Identifies eligibility for specific targeted therapies |
Conditions that May Affect NextGen AML Stratification NGS Panel Accuracy
Several factors can influence the quality and accuracy of your NextGen AML Stratification NGS Panel results:
- Sample quality: Haemolysed, clotted, or insufficient samples may affect results.
- Previous chemotherapy: Treatment may alter genetic profiles in cancer cells.
- Bone marrow involvement: Low blast count may impact mutation detection.
- Sample storage conditions: Improper temperature during transport can degrade DNA.
- Medication interference: Certain drugs may affect cellular DNA integrity.
- Sample contamination: Improper collection techniques can compromise results.
How Is the NextGen AML Stratification NGS Panel Done?
The test process involves careful sample collection and advanced laboratory analysis:
- Sample collection: Blood is drawn from a vein, or bone marrow is aspirated by a specialist.
- Sample preparation: DNA is extracted from cancer cells in the laboratory.
- Genetic sequencing: Advanced NGS technology reads the genetic code of cancer cells.
- Data analysis: Sophisticated software identifies mutations and genetic changes.
- Report generation: Results are compiled into a comprehensive clinical report.
- Quality control: Multiple checks ensure the accuracy and reliability of findings.
How Should You Prepare for the NextGen AML Stratification NGS Panel?
Preparing for this genetic test is straightforward and requires minimal preparation:
- No fasting required: You can eat and drink normally before the test.
- Continue medications: Take all prescribed medicines as usual unless advised otherwise.
- Stay hydrated: Drink adequate water to make blood collection easier.
- Inform your doctor: Share details about all medications and supplements you're taking.
- Comfortable clothing: Wear clothes that allow easy access to your arm for blood collection.
Diseases that the NextGen AML Stratification NGS Panel Can Help Detect
This specialised genetic panel focuses specifically on acute myeloid leukaemia and related health conditions:
- Acute Myeloid Leukaemia (AML): Primary focus for genetic subtyping and risk assessment
- AML with specific genetic mutations: Identifies distinct subtypes requiring different treatments
- Therapy-related AML: Detects genetic changes associated with treatment-induced leukaemia
- AML with myelodysplasia-related changes: Identifies specific genetic patterns
- Secondary AML: Genetic profiling of leukaemia arising from other blood disorders
NextGen AML Stratification NGS Panel/Packages that You Can Book With Metropolis Healthcare
The following table shows comprehensive testing options available at Metropolis Healthcare for blood cancer evaluation:
|
Test/Package Name |
Purpose/Highlights |
|
Comprehensive screening for acute blood cancers |
|
|
Specialised testing for chronic blood disorders |
|
|
Monitors heart health during cancer therapy |
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.